Skip to main content
. Author manuscript; available in PMC: 2016 May 2.
Published in final edited form as: J Obes Weight Loss Ther. 2015 Mar 30;5(2):253. doi: 10.4172/2165-7904.1000253

Table 2. Between group differences in primary outcome and hypothesized mediators at baseline, 6-, 12-, and 24-month follow-up measurement points, M (SD).

Weight, lbs Disinhibition Restraint

Baseline, N=442
 INT 203.6 (23.9) 9.0 (3.4) 10.1(4.2)
 UC 200.1 (22.9) 9.1 (3.5) 9.8 (4.2)
 p-value .19 .85 .58
6-Month, N=428
 INT 184.1 (24.2) 7.3(3.4) 14.7(3.4)
 UC 191.9 (23.8) 8.0 (3.9) 13.0(4.7)
 p-value .005 .10 .001
12-Month, N=408
 INT 181.3 (26.6) 7.9 (3.7) 14.0(3.7)
 UC 192.5 (25.7) 7.9 (3.9) 12.2(5.0)
 p-value .0003 .89 .01
24-Month, N=387
 INT 186.6 (28.7) 7.8 (3.7) 13.7(4.3)
 UC 194.5 (27.1) 7.9 (3.8) 12.2(4.9)
 p-value .02 .83 .006

INT- Intervention groups

UC- Usual care comparison group

HHS Vulnerability Disclosure